Guidewire Pays $1.7 Billion to Bring AI Into Insurance Pricing
Guidewire will pay $1.7 billion in cash, plus up to $400 million more, for hyperexponential, an AI-native pricing firm. The core-systems vendor is buying a decision engine and funding part of it with new debt.
Guidewire Software agreed October 27, 2026 to acquire Hyperexponential Ltd (hyperexponential, or hx) for a base purchase price of $1.7 billion in cash, subject to adjustments, plus up to $400 million in contingent consideration tied to hitting specified recurring-revenue targets. Guidewire already supplies core policy, billing, and claims systems to insurers. hyperexponential sells AI-native underwriting and pricing software to commercial and specialty property-and-casualty insurers, reinsurers, and managing general agents.
The London firm was already a Guidewire PartnerConnect Technology Alliance Partner. It says it has powered underwriting decisions across more than $75 billion in annual commercial P&C premium. Guidewire CEO Mike Rosenbaum is buying that former partner. hyperexponential CEO and co-founder Amrit Santhirasenan built it.
Guidewire sits on the insurance system of record, the core platforms carriers are slow to replace. It is now paying a steep cash-and-debt price for a system of decision: software that assesses and prices commercial risk. The check treats AI-native pricing as the next layer of insurance software value, and it is large relative to the recurring revenue the deal is expected to add.
About $80 million of ARR, at 20 times plus
Guidewire expects the deal to add at least 650 basis points to its fiscal 2027 annual recurring revenue growth on an inorganic basis, then at least 150 basis points to durable organic ARR growth starting in fiscal 2028. Six hundred fifty basis points is 6.5 percent. Against Guidewire's roughly $1.24 billion ARR base, that is about $80 million of ARR. A $1.7 billion base price against that figure implies a deal price of roughly 20x-plus annual recurring revenue, a multiple that reflects a trajectory rather than current scale.
Guidewire's fiscal 2026 results, for the year ended July 31, 2026, show both the capacity and the gap. Total revenue was $1,475.4 million, up 23 percent year over year. ARR was $1,242 million, up 19 percent on a constant-currency basis, or $1,237 million revalued at July 31, 2026. Subscription and support revenue was $970.9 million, up 33 percent. Cash, cash equivalents, and investments were $1,215.3 million. Operating cash flow was $389.7 million. The company serves more than 570 insurers across 44 countries.
Press reporting has described hyperexponential as founded in 2017, backed by venture investors including Andreessen Horowitz and Battery Ventures, and as having raised on the order of $90 million to date. Guidewire's own materials do not rest the case on that history. They rest it on the commercial premium hx already touches and on the ARR growth the acquisition is expected to contribute.
A term loan, cash on hand, and a fiscal 2027 close
Guidewire will fund the acquisition with $1.0 billion in new term-loan financing and existing cash on hand. It secured a binding debt commitment. The $1.7 billion base price exceeds the $1,215.3 million cash pile, which is why the term loan is in the structure. The extra $400 million, if earned against recurring-revenue targets, would raise total consideration toward $2.1 billion.
The deal is expected to close in the second quarter of Guidewire's fiscal 2027. It has no impact on Guidewire's Q1 fiscal 2027 guidance issued September 3, 2026. That close window is also when the inorganic 650-basis-point ARR lift is supposed to show up in fiscal 2027. The 150-basis-point organic contribution is a fiscal 2028 claim. The earnout sits in between: extra cash only if the specified recurring-revenue targets are hit.
Guidewire did not need to buy hx to keep the product in its ecosystem. The firm was already a technology alliance partner. Buying it at this price converts a complementary pricing engine into a captive one, and it does so with new term-loan debt. The bet is that commercial insurers will pay for AI-native underwriting inside the same relationship that already runs the core, and that the ARR path implied by those 650- and 150-basis-point targets is worth a 20-times-plus cash check.
